Smoking Cessation & Nicotine De-Addiction Market Worth $21.8 Billion By 2024

The global smoking cessation and nicotine de-addiction market is expected to reach over USD 21.8 billion by 2024 according to a new report by Grand View Research, Inc.

The base of population addicted to smoking is rapidly increasing across the globe. This population subset majorly includes teenagers and the working population. Smoking-related mortality is very high. The increasing desire to quit smoking and the numerous health complications associated with smoking serve as strong incentives for companies to introduce novel smoking cessation products, such as Revolymer, which has introduced the next generation nicotine gums to help smokers quit smoking. The launch of these improved and innovative nicotine replacement therapy products is to serve as a high impact rendering driver for the growth of the smoking cessation and nicotine de-addiction market.

The growing incidence of target diseases such as chronic obstructive pulmonary disease (COPD), asthma, cardiac diseases, and lung cancer, and the increasing awareness pertaining to the hazardous side-effects of smoking are the factors expected to promote market expansion. Educational institutions remain active in organizing various campaigns and programs to spread information about the harmful effects and consequences of smoking so as to increase young population awareness.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/smoking-cessation-and-nicotine-de-addiction-products-market

Further key findings from the study suggest:

Nicotine Replacement Therapy (NRT) dominated the smoking cessation and de-nicotine addiction product market in 2015. Majorly used NRT products include nicotine chewing gums and the transdermal patches. Increased availability and the introduction of the ingestible nicotine products with different flavors are the factors responsible for its large market share.
The e-cigarette segment is anticipated to grow at a CAGR of19.0% over the forecast period. The major factors responsible for the growth of the E-cigarette market include the introduction of second and third generation e-cigarettes, the availability of various flavored products, the presence of numerous vendors operating and selling e-cigarettes under different brand names.
North America held a large market share of over 35.0% in 2015 owing to the high awareness levels of nicotine de-addiction products with around 90% of the U.S. population were identified as aware of e-cigarettes in 2015
Asia Pacific is the fastest growing market. The registration of nicotine de-addiction products and e-cigarettes as well as the strengthening of the company distribution channels in countries, such as China, India, and Australia are expected to support the growth over the forecast period
Some key players of this market are Pfizer, Inc., Cipla Ltd., Novartis International AG, GlaxoSmithKline plc, Takeda pharmaceutical Company Ltd., McNeil AB, Revolymer plc, Imperial Tobacco Ltd., and VMR products, LLC
The market players are making slow but steady progress in the e-cigarette market by focusing on the development, commercialization, and distribution of the FDA approved nicotine products. For instance, in 2014, Victory Electronic Cigarettes Corporation acquired Ten Motives Ltd. with an aim to expand their distribution channels and attain wider market coverage.

Biosimilars Market Size Worth $61.47 Billion By 2025

The global biosimilars market size is expected to reach a value of USD 61.47 billion by 2025, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 34.2% over the forecast period. Major biological drugs are approaching the patent cliff. This is the most significant driving factor for the market. For instance, Roche’s MabThera/Rituxan (rituximab), a monoclonal antibody biologics was approved by the U.S. Food and Drug Administration (FDA) in November 1997 and its U.S. patent expired in September 2016. Several companies such as Amgen, Boehringer Ingelheim, and Pfizer are focusing on the development of biosimilar drugs of rituximab.

Furthermore, the lower cost of biosimilars compared to patented biologics and positive outcomes in clinical trials are expected to boost market growth. For instance, in July 2016; Allergan plc and Amgen stated results from a Phase 3 clinical study of ABP 980 compared with trastuzumab, a recombinant DNA-derived humanized monoclonal antibody. This drug was approved for early and metastatic breast cancer and metastatic gastric cancer in many regions. Currently, there is a boom in the pharmaceutical industry for the development of biosimilar drugs, which is a cost-saving alternative to biologic drugs. Amgen Inc.; Sandoz International GmbH; Teva Pharmaceutical Industries Ltd.; Pfizer Inc.; Biocon; Samsung Bioepis; and Mylan N.V are some of the companies focusing on the development and production of biosimilars.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/biosimilars-market

Further key findings from the report suggest:

In 2016, the recombinant non-glycosylated protein was the largest revenue-grossing segment in the biosimilars market owing to the prevalence of growth hormone deficiency and diabetes and other chronic diseases
Recombinant glycosylated protein segment is expected to grow at a significant rate during the forecast period owing to demand erythropoietin and monoclonal antibodies for the treatment of cancer and anemia
Oncology accounted for the largest share in the application segment in 2016 due to increasing adoption of low-cost biosimilar drugs for cancer treatment
Europe was the leading regional segment in terms of revenue share in 2016 owing to favorable regulatory policies
North America is expected to witness the highest CAGR during the forecast period owing to the high prevalence of chronic diseases and a rising number of drug approvals
Some of the major players are Amgen Inc.; F. Hoffmann-La Roche Ltd.; Sandoz International GmbH; Dr. Reddy’s Laboratories Ltd.; Teva Pharmaceutical Industries Ltd.; Pfizer Inc.; Samsung Bioepis; Biocon; and Mylan N.V.

Allergy Diagnostics & Therapeutics Market Worth $51.95 Billion By 2026

The global allergy diagnostics and therapeutics market size is expected to reach USD 51.95 billion by 2026 registering a CAGR of 6.3%, according to a new study by Grand View Research, Inc. Increasing prevalence of allergic conditions coupled with adoption of immunoassay as diagnostic test is expected to serve this market with lucrative growth opportunities. According to the report published by the World Allergy Journal in May 2014, around 300 million cases of asthma and 200 to 250 million cases of food allergies were reported. This number is expected to increase over the forecast period due to sedentary lifestyle and poor dietary habits.

Rising industrial pollution, rapid urbanization in developing countries, and increasing Greenhouse Gas (GHG) concentrations are expected to result in increased prevalence of pollen induced respiratory disorder, thereby boosting the overall market growth over the forecast period. Emergence of technologically advanced products, such as MeDALL allergen-chip for allergy determination, is further expected to propel the market growth in the years to come.

The global market is highly competitive and is led by companies including Thermo Fisher Scientific, Omega Diagnostics, Siemens Healthcare, Stallergenes Greer, Lincoln Diagnostics, bioMerieux, HOB Biotech Group, Alcon Laboratories, Hycor Biomedical, and Hitachi Chemical Diagnostics. Most of the industry participants focus on the development of advanced products and technologies to gain competitive advantage. For instance, in March 2015, Stallergenes received approval for STG 320 in Japan, which is the first sublingual immunotherapy tablet used in the treatment of house dust mite allergy.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/allergy-diagnostic-market

Further key findings from the study suggest:

Instruments product segment is anticipated to witness the highest CAGR of 12.2% from 2019 to 2025 due to high demand for analyzers and laminators for allergy diagnostics
In vitro is expected to be the largest as well as fastest-growing test segment over the estimated period on account of rising demand for minimally invasive and allergen-specific tests
Antihistamines drug class led the allergy diagnostics and therapeutics market in 2018 due to its advantages, such as non sedating nature and minimum side effects with use of second generation antihistamines in allergy treatment
Immunotherapy vaccines is expected to register the maximum CAGR from 2019 to 2025 owing to extensive R&D in the field and advent of sublingual immunotherapy tablets in the treatment of allergic rhinitis
For instance, in April 2014, the U.S. FDA approved a five-grass pollen sublingual tablet (Ex-Oralair) by Stallergenes, which is used in the treatment of pollen allergy

Rigid Packaging Market Worth $848.71 Billion By 2025

The global rigid packaging market size is projected to reach USD 848.71 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 6.7% during the forecast period. Increasing demand for sustainable packaging is expected to augment the market over the forecast period.

Packaging is a process of protecting and enclosing goods for storage, distribution, and sale. Rigid packaging is a type of packing which is characterized by high stiffness, impact strength, and barrier properties. It is offered in several forms, including jars, containers, bottles, and cans.

Raw materials required for manufacturing of rigid packing include metals, paper & paperboard, glass, and plastic. Suppliers of these materials are present worldwide, making the market fragmented. Rio Tinto and Alcoa are some of the key suppliers of metals such as aluminum, while ArcelorMittal is the largest steel manufacturer in the world.

Final products are sold by distributors, retailers, and wholesalers. Major players in this stage include Packaging Supplies Ltd., Packing Suppliers of America, Paper Mart, and Packaging Centre. Some of the manufacturers have adopted integration wherein they sell the products through exclusive outlets.

Rigid packaging accounted for over 80.0% of the total packing industry in 2016. However, flexible packing offers more advantages as compared to rigid ones such as lightweight, energy savings, small pack size, ease of transportation & storage, and convenient disposal. Hence, the flexible packing market is expected to make inroads in the rigid packaging market in the coming years.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/rigid-packaging-market

Further Key Findings from the Report Suggest:

In terms of materials, plastics dominated the market in 2015 and it is anticipated to witness a CAGR of 6.4% in terms of volume over the forecast period
Paper & paperboard is expected to register a CAGR of 7.1% in terms of revenue during the same period. Recyclability of the material has made it the most commonly used product in the industry
The personal care application segment is anticipated to rise at a CAGR of 6.3% in terms of revenue over the coming year due to increasing demand for personal care products
Asia Pacific is estimated to post a CAGR of 7.6% in terms of revenue from 2016 to 2025 due to increasing demand from China and India
In August 2016, Berry Plastics Group, Inc. acquired AEO Industries Inc. in the U.S. This acquisition strengthened the company’s position in the North America market.

Aseptic Packaging Market To Reach $85.47 Billion By 2024

The global aseptic packaging market is expected to reach USD 85.47 billion by 2024, according to a new report by Grand View Research, Inc. Aseptic packaging allows the end –users to meet the consumer demand for sterile and safe food and pharmaceutical products. The technology offers extended shelf stability at ambient temperature, which eliminates the need for refrigeration. As a result, aseptic packaging is expected to witness high demand from the foodservice entities and retailers.

The aseptic packaging manufacturers supply their product either in the form of rolls or blanks. The roll-fed filling technique dominates the market and has been adopted by the major manufacturers such as Tetra Pack. Whereas, companies such as Elopak and SIG have adopted the blank filled systems. These two technologies are not interchangeable since the process and equipment associated with these two methods are different. As a result, buyers are unable to switch from one process to other. High capital investment is likely to be a key restraining factor for the industry.

Investment, Divestment, capacity expansion and new product development are the key strategies adopted by the major players in order to strengthen their position in the market. The industry players are likely to invest more on R&D and innovation owing to continuously changing demand from end-users in terms of product quality, performance, and appearance. The major manufacturers are likely to adopt acquisition strategies in order to meet the rising consumer demand and cope with the new technologies.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/aseptic-packaging-market

Further key findings from the report suggest:

The food was the key application segment for the industry and is expected to grow at a CAGR of over 11% over the next eight years. The process is carried out at lower temperatures. Thus the texture, appearance, flavor and nutritional value of the products remains unaffected. In addition, light weight and recyclability offered by aseptic packaging are expected to have a positive impact on the industry growth over the forecast period.
Prefilled syringes demand in the industry was valued over 4.5 billion in 2015 and is expected to grow at a CAGR of over 11% from 2016 to 2024. Advances in biotechnology and rising demand for biologics is anticipated to drive demand over the eight years. The technology offers safety against drug degradation and contaminants. Furthermore, it eliminates the need for refrigeration and thus lowering the cost associated with the maintenance of the product.
Asia Pacific is expected to be the fastest growing market owing to rapid growth of food and beverage packaging sector in the region. China was the largest market for aseptic packaging in Asia Pacific and accounted for over 50% of the regional demand in 2015. Increasing consumer disposable income and changing dietary habits in countries such as India, China, Japan, and Korea are expected to raise demand for packaged ready-to-eat meals, frozen meat, and juices, which is anticipated to have a positive impact on the industry growth over the projected period.
The key players in the industry are The key players in the market include Robert Bosch GmbH, Tetra Pak International S.A., Greatview Aseptic Packaging Co., Ltd., Schott AG, SIG Combiboc Obeikan, Reynolds Group Holdings Limited, and Agropur Inc.

N-Methyl-2-Pyrrolidone (NMP) Market Size Worth $1.79 Billion By 2025

The global n-methyl-2-pyrrolidone (NMP) market is expected to reach USD 1.79 billion by 2025, according to a new report by Grand View Research, Inc. The NMP market is expected to witness significant growth over the forecast period owing to the increasing demand from Asia Pacific region.

NMP is used in a various applications including oil & gas, pharmaceutical, electronics, paints & coatings, agrochemicals and others. Emerging economies such as India are witnessing increasing FDI which is fueling the growth of industrial sector. Asia Pacific region is expected to witness higher growth rates owing to rapid urbanization in these countries coupled with per-capita disposable income levels.

Oil & gas dominated the market for NMP globally. The other key applications include electronics, pharmaceuticals, paints & coatings and agrochemicals.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/n-methyl-2-pyrrolidone-nmp-market

Further key findings from the report suggest

Globally, electronics and oil & gas application segments are expected to witness significant volume growth during the forecast period, growing at CAGRs of over 4% during the forecast period. This growth can be attributed to rapid growth from the end-use verticals such as petrochemical refineries, and electronics & telecommunication.
Asia Pacific dominated the NMP market in 2015 with an estimated revenue of around USD 450 million, and is projected to grow significantly over the coming years owing to the increasing investments from the application industries. China is expected to witness an increase in demand and expected to be the largest consumer of petrochemical products owing to presence of large capacity manufacturing units and favorable export-oriented government policies. Russian oil company Transneft has constructed Eastern Siberia Pacific Ocean (ESPO) Pipeline which provides Russia an option to supply crude oil to China.
Key participants in the N-Methyl-2-Pyrrolidone market include BASF SE, E. I. du Pont de Nemours and Company, Eastman Chemical Company, Mitsubishi Chemical Corporation, and Ashland Inc., among others. In recent years, new product developments have been the major growth strategy adopted by key market players for strengthening their market positions.

Bag On Valve Products Market Size Worth $9.55 Billion By 2025

The global bag on valve products market size is expected to reach USD 9.55 billion by 2025, registering a 6.8% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Rising demand for personal care, household care pharmaceutical, and other products coupled with advanced packaging offered by the product is likely to benefit the industry growth.

Factors such as changing lifestyle, growing disposable incomes are likely to boost the demand for personal care products including deodorants, liquid soap & shampoo, hair gels & shaving, and cosmetics. In addition, the demand for advanced packaging solutions and minimum product wastage is projected to propel the market.

The bag on valve packaging offers superior benefits such as benefits such minimum product wastage, ease in usage and convenience in carrying. In addition, the bag on valve packaging technology helps in achieving a zero amount of product contamination, which is likely to stimulate the demand for the products leading to growth over the next seven years.

The introduction of fully recyclable bag on valve products augments their demand in various application segments including pharmaceuticals, food & beverage, automotive and industrial. Limited requirement of aerosol propellants in the aforementioned packaging is expected to fuel the substitution of conventional aerosols which in turn is expected to fuel growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/bag-on-valve-products-market

Further key findings from the report suggest:

The bag on valve products in pharmaceutical sector accounted for a share of 37.9% in terms of revenue in 2018, owing to wide range of applications in products such as nasal spray, wound cleaners, among others
The food & beverage application segment is anticipated to grow at a CAGR of 7.6% from 2019 to 2025 and is projected to reach USD 2,295.9 million in 2025 owing to widespread adoption of the product drive by ease in dispensing
Asia-Pacific bag on valve products market is estimated to grow at a CAGR of 8.2% from 2019 to 2025 on account of rapid expansion of the manufacturing sector coupled with increased spending power of the consumers in the region
The technological advancements in North America coupled with the demand for convenient packaging solutions is anticipated to benefit the regional market growth which is expected to exhibit a CAGR of 7.2% over the forecast period
Market participants across the globe have increased their R&D spending in order to develop highly efficient products for various applications in a bid to facilitate product adoption by the consumer industries

Gum Arabic Market Size Worth $555.9 Million By 2025

The global gum arabic market size is expected to reach USD 555.9 million by 2025, according to a new report by Grand View Research, Inc., exhibiting a 5.9% CAGR during the forecast period. Gum arabic, also known as acacia gum, is a natural emulsifier used in various applications such as food and beverage, cosmetics, pharmaceuticals, and paints. It is primarily used as a filling and thickening agent in most confectionery items.

The market is driven by increasing consumer spending on dietary and fiber-rich food products, especially in bakery applications. This can be attributed to growing purchasing power of consumers, along with significant spending in the beverage and confectionery industry in developing countries such as China and India. Rapidly growing bakery industry in several Asian and South American countries and with a rise in sales of natural and functional ingredients used in bakery products are key trends benefiting this market. Moreover, the ability of this ingredient to be instantly soluble in products and help retain flavors, colors, and aromas in various foods and beverages is expected to support product demand.

The ingredient plays a crucial role in dairy products, as an encapsulation medium and stabilizer. Its air-holding ability improves freeze-thaw stability in ice creams, yogurts, and other frozen desserts. Thriving e-commerce channels and increasing number of domestic bakery vendors have been providing players major opportunities for growth.

The market in North America held the dominant share of over 35.0% in 2018 and this can be attributed to a large consumer base, especially for beverages, confectioneries, and pharmaceutical products. Soaring sales of dairy products, particularly in countries like Japan, China, Australia, and India have been driving the Asia Pacific market, enabling it to register the fastest growth over the forecast period.

The market is characterized by several growth initiatives, such as acquisitions, mergers, online sales, and investment in research and development. Key players in the market include Gum Arabic Company; Nexira; Kerry Group; Tic Gums Inc.; Agrigum International Limited; Farbest Brands; Archer Daniels Midland Company; Ashland Inc.; Hawkins Watts; and Prodigy NIG Limited.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/gum-arabic-market

Further key findings from the report suggest:

In terms of revenue, dairy products are expected to emerge as the fastest growing application segment, registering a CAGR of 7.4% over the forecast period. The ingredient serves as an effective encapsulation medium and stabilizer in dairy products
By source, acacia Senegal dominated the global market with a share of 66.2% in 2018. These trees are known to yield in all seasons, regardless of soil texture and condition
North America dominated the global market in 2018, accounting for 35.7% of the overall revenue. Growing beverage and dairy industries, driven by rising consumption of ready-to-eat foods, is expected to propel the gum arabic market
The industry is highly competitive in nature. Key players include Gum Arabic Company; Nexira; Kerry Group; Tic Gums Inc.; Agrigum International Limited; Farbest Brands; and Archer Daniels Midland Company
Manufacturers are concentrating on new product launches, capacity expansions, and technological innovation to estimate existing and future demand patterns.

Quillaia Extract Market Size Worth $1.05 Billion By 2025

The global quillaia extracts market size is anticipated to reach USD 1.05 billion by 2025, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% over the forecast period. Increasing consumption of natural ingredients, changing food habits, and wide range of applications of the product in industries such as food and beverage, medical, and personal care among others are anticipated to drive the growth.

Quillaia extract is largely used for manufacturing cream soda, cider, puddings, baked goods, and frozen dairy products among other food and beverages. The extract is used in different quantities in different products. For instance, in carbonated beverages, the concentration of quillaia extract is upto 200mg/kg wherein in noncarbonated drinks, it is used upto 500mg/kg. Food and beverage held the largest market share of 36.45% in 2018, owing to the rising demand for foam stabilizing agents. The product is water soluble foaming compound that helps maintain temperature, taste, and shelf stability, which drive the application.

Increasing demand for organic and natural skincare products is anticipated to bode well for the quillaia extract market. One of the market players, Desert King offers different types of quillaia extract, namely, Andean Pure Quillaia, Andean Q Ultra, Andean Q Ultra Organic, Andean QDP Ultra Organic, Andean QE, and Andean QD for cosmetic application.

Liquid quillaia product type is anticipated to expand at a CAGR of 5.3% over the forecast period. The liquid extract is smooth and textureless making it suitable for curries and sauces. It is widely used as a foaming agent in soft drinks such as ginger beer, root beer, and cream soda, and in cocktails among other drinks. It has sweet and pungent smell and turns into foam upon shaking, hence it finds application in personal care application. For instance, Puracy, uses liquid quillaia extract in its natural conditioners, shampoos, and skin care products.

Asia Pacific held the largest market share of over 32% in 2018, due to high product consumption in Australia and New Zealand. According to a report by the Bureau of Chemical Safety, the mean quillaia extract intake in Australia was 2.3mg/kg per day and 1.1 mg/kg per day in New Zealand. The quillaia extract is also known as China bark extract, as the quillaia trees are native to China. The product is widely used in food products like soy sauce. High demand for organic and natural cosmetics in India, China, and Japan will boost the regional growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/quillaia-extracts-market

Further key findings from the report suggest:

Food and beverage segment held the largest market share of 36.45% in 2018 and is anticipated to continue leading during the forecast period
Liquid product type is anticipated to expand at a CAGR of 5.4% over the forecast period
Asia Pacific held the largest share of the global quillaia extract market in 2018
Leading market players are Garuda International, Naturex, Ingredion, Stan Chem International, Desert King, Baja Yucca, and Chile Botanics among others

Folic Acid Market Size Worth $466.2 Million By 2025

When it comes to Folic Acid Market, there are several factors which are causing the market to grow leaps & bounds. Increasing consumption of folic acid in promising applications in various verticals of pharmaceuticals and nutraceuticals sectors coupled with strict regulations is expected to propel the global market demand. Raising its utilization in food and beverage industry to increase the folic acid food fortification particularly in developed economies such as North America and Europe is also predicted to impact the global folic acid market positively. All these factors along with several other positive ones lead the market to reach expected growth of USD 466.2 million by 2025, according to a new report by Grand View Research, Inc.

Folic acids or Folate or vitamin B9 is a type of water-solvent vitamin required by the body to produce red platelets, and its deficiency causes anemia. Additionally, it is involved in the normal body development and advancement, generation of genetic materials, for example, DNA and RNA and other essential chemical & physical functions. It encourages cell and tissue growth and development. Folic acid is used in multivitamins supplements because it is better absorbed.

Folic acid support fetal development by preventing the risk of birth defects promotes sperm viability, improves cardiovascular system by minimizing the risk of heart attack, encourages normal cholesterol levels, provides neurological support, and helps perinatal mood management. Vitamin B9 is an essential nutrient found green and leafy vegetables, peas, broccoli, oranges, corn, grains meats, and cereal. Significant folic acid deficiency can lead to macrocytic anemia

Click the link below:
https://www.grandviewresearch.com/industry-analysis/folic-acid-market

Further key findings from the report suggest:

Rising occurrence of diseases and pandemic like COVID-19 makes it essential to develop new set of pharmaceuticals; and rising growth of pharmaceuticals and neutraceuticals leads to spurt in the growth of Folic Acid demand.
According to WHO, Globally, anemia affects 1.62 billion people, which corresponds to 24.8% of the population. The highest prevalence is in preschool-age children and the lowest prevalence is in men. Folic acid has proven benefits in fighting anemia. Large anemia affected population causes a growth in demand for Folic Acid.
Folic Acid is used in body supplements and is involved in the normal body growth & development, production of genetic materials such as DNA and RNA and several other bodily functions. This makes it indispensable for the healthcare industry.
Folic acid food fortification has been made compulsory in many developed economies such as the U.S., New Zealand, UK, and Australia. This fuels the market as well.
Folic Acid plays a major role in providing support to a pregnant mother in taking care of the baby, leading to the increased demand in the market.
Folic Acid is used in additives for the animal feed to help them grow devoid of any deformities and boost their immune system, leading to additional demand in the market.
Some Environment Protection Laws work against the manufacturing of Folic Acid. This proves to be an inhibiting factor for the market.
In the time pandemic (COVID-19), it is extremely important to keep your immune system at its peak. According to scientists, Folic Acid has several immune related benefits and along with other B complex vitamins, it plays a major role in keeping immune system up and running. In India, the National Nutrition Mission (NNM) has been set up with a three year budget of Rs.9046.17 crore commencing from 2017-18. The NNM is a comprehensive approach towards raising nutrition level in the country on a war footing. Iron and Folic Acid (IFA) supplements will be given and mapped in the country.